This approximately 3,000 to 5,000-fold difference in half-life represents the primary pharmacological divergence between the endogenous hormone and its synthetic analog
High-dose vitamin C as a metabolic treatment of cancer: a new dimension in the era of adjuvant and intensive therapy
Abstract Background Cancer, being a complex disease, presents a major challenge for the scientific and medical communities
The variation in C max within the normal renal function group was larger than the renal impairment groups owing to outlying profiles with low exposure
In cell cultures, liposomal glutathione has been demonstrated to be 100 times more efficiency for intracellular delivery than non-liposomal glutathione.*
The frequency and intensity of surveillance should be individualized based on baseline cancer risk, duration of peptide therapy, and the presence of any concerning symptoms or clinical findings